NCT05709990View on ClinicalTrials.gov

Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children

NACompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

June 3, 2023

Study Completion Date

June 15, 2023

Conditions
Overactive Bladder
Interventions
DRUG

Solifenacin Succinate 5 MG Oral Tablet [Vesicare]

These patients will receive solifenacin 5-10 MG daily (combined with standard urotherapy) for 8 weeks.

DRUG

Vitamin D3

These patients will receive high dose vitamin D supplementation (more than 2000IU daily) (combined with standard urotherapy) for 8 weeks.

BEHAVIORAL

Standard urotherapy

These patients will receive standard urotherapyfor 8 weeks.

Trial Locations (1)

400000

Children's Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

Xing Liu

OTHER